Extended Product Pipeline
HERBORIUM
is working on several additions to its Product Portfolio. The near term products
under development and consideration include:
- The Liver Activator
Series® Complimentary Liver Support Products that target liver damage
resulting from Hepatitis C, Hepatitis B, and Cirrhosis and focus on regaining
liver wellness compromised by alcohol, drugs and environmental factors. The leading
product that supports both liver wellness and treatment is Liver Rejuvenator®
- ProstAid an all natural product focused on Benign Prostate
Hyperplasia (BPH) and ProstCare a similar product that targets Prostatitis
- CardioVitae® a proprietary, fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. An enriched extract derived from a Ganoderma lucidium cell line that helps improve and accelerate recovery from cerebrovascular strokes is also under consideration.
The
Company focuses on health needs with large market potential as defined
by the number of patients and the demonstrated need for more
satisfactory medical solutions.
Additional priority products identified by Herborium include:
- Men’s Health (Benign Prostate Hyperplasia)
- Hepatic Disease including Hepatitis and Cirrhosis and Improve hepatic function in patients with chronic liver disease
- Antibiotic resistant pulmonary infections
- Rheumatoid Arthritis
- Cancer
- Diabetes
Investors News Sign Up
Contact Herborium Group, Inc.
Phone: 1.201.849.4431
E-mail: InvestorsRelations@Herborium.com
E-mail: InvestorsRelations@Herborium.com